Contact Us | For Limited Partners

Acquisition
and Growth Capital

ABOUT CRP | PORTFOLIO COMPANIES | CRP TEAM | IN THE NEWS

CRP in the News
December 2007

 


Prometheus Laboratories Files an IPO

Prometheus Laboratories Inc., a San Diego-based pharmaceutical company, has filed an initial public offering with the Securities and Exchange Commission. VentureWire also reported that Prometheus plans to sell up to $100 million in common stock.

Prometheus is a specialty pharmaceutical company that markets and sells branded pharmaceutical (therapeutic) and diagnostic (test) products in the United States. The Company focuses on treating digestive diseases and disorders associated with the gastrointestinal tract as well as creating a highly focused, specialty pharmaceutical company built on a foundation of consultative relationships with specialty gastrointestinal ("GI") and rheumatology ("RA") physicians.

 

return to CRP in the News >